Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention
Desai, Nihar R, Canestaro, William J, Kyrychenko, Pavlo, Chaplin, Donald, Martell, Lori A, Brennan, Troyen, Matlin, Olga S, Choudhry, Niteesh K
Published in Circulation Cardiovascular quality and outcomes (01.11.2013)
Published in Circulation Cardiovascular quality and outcomes (01.11.2013)
Get full text
Journal Article
Healthcare payers: a gate or translational bridge to personalized medicine?
Canestaro, William J, Martell, Lori A, Wassman, E Robert, Schatzberg, Rick
Published in Personalized medicine (01.01.2012)
Published in Personalized medicine (01.01.2012)
Get full text
Journal Article
A phase I open-label study of Ad-RTS-hIL-12, an adenoviral vector engineered to express hIL-12 under the control of an oral activator ligand, in subjects with unresectable stage III/IV melanoma
Linette, Gerald P., Hamid, Omid, Whitman, Eric D., Nemunaitis, John J., Chesney, Jason, Agarwala, Sanjiv S., Starodub, Alexander, Barrett, John A, Marsh, Andrew, Martell, Lori A., Cho, Angela, Reed, Thomas D., Youssoufian, Hagop, Vergara-Silva, Andrea
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article